Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Assembly 12: interstitial lung diseases.

Antoniou K, Trachalaki A, Bibaki E, Poletti V.

Breathe (Sheff). 2018 Dec;14(4):345-346. doi: 10.1183/20734735.026518.

2.

Pirfenidone improves survival in IPF: results from a real-life study.

Margaritopoulos GA, Trachalaki A, Wells AU, Vasarmidi E, Bibaki E, Papastratigakis G, Detorakis S, Tzanakis N, Antoniou KM.

BMC Pulm Med. 2018 Nov 23;18(1):177. doi: 10.1186/s12890-018-0736-z.

3.

Paroxysmal cough and left sacroiliac joint pain in a 50-year-old Caucasian man.

Proklou A, Bolaki M, Vassalou EE, Bibaki E, Vasarmidi E, Margaritopoulos GA, Karantanas AH, Tzanakis N, Antoniou KM.

Breathe (Sheff). 2018 Jun;14(2):e59-e67. doi: 10.1183/20734735.018818.

4.

Investigation of key autophagy-and mitophagy-related proteins and gene expression in BALF cells from patients with IPF and RA-ILD.

Vasarmidi E, Sarantoulaki S, Trachalaki A, Margaritopoulos G, Bibaki E, Spandidos DA, Tzanakis N, Antoniou K.

Mol Med Rep. 2018 Oct;18(4):3891-3897. doi: 10.3892/mmr.2018.9356. Epub 2018 Aug 6.

5.

miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns.

Bibaki E, Tsitoura E, Vasarmidi E, Margaritopoulos G, Trachalaki A, Koutoulaki C, Georgopoulou T, Spandidos DA, Tzanakis N, Antoniou KM.

Mol Med Rep. 2018 May;17(5):7105-7112. doi: 10.3892/mmr.2018.8778. Epub 2018 Mar 19.

6.

Clinical applications of mesenchymal stem cells in chronic lung diseases.

Antoniou KM, Karagiannis K, Tsitoura E, Bibaki E, Lasithiotaki I, Proklou A, Spandidos DA, Tzanakis N.

Biomed Rep. 2018 Apr;8(4):314-318. doi: 10.3892/br.2018.1067. Epub 2018 Feb 16.

7.

Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis.

Samara KD, Trachalaki A, Tsitoura E, Koutsopoulos AV, Lagoudaki ED, Lasithiotaki I, Margaritopoulos G, Pantelidis P, Bibaki E, Siafakas NM, Tzanakis N, Wells AU, Antoniou KM.

Respir Res. 2017 Dec 29;18(1):218. doi: 10.1186/s12931-017-0692-9.

8.

Clinical highlights from the 2016 European Respiratory Society International Congress.

Kahn N, Fregonese L, Barrecheguren M, Franssen FME, Grgic A, Gompelmann D, Bibaki E, Antoniou KM, Kocks JWH, Pinnock H, Herth F.

ERJ Open Res. 2017 Apr 12;3(2). pii: 00147-2016. doi: 10.1183/23120541.00147-2016. eCollection 2017 Apr.

9.

Controversies in Fibrosis and Emphysema.

Antoniou KM, Bibaki E, Margaritopoulos GA.

Arch Bronconeumol. 2017 May;53(5):231-232. doi: 10.1016/j.arbres.2017.02.003. Epub 2017 Mar 23. English, Spanish. No abstract available.

10.

MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells.

Tsitoura E, Wells AU, Karagiannis K, Lasithiotaki I, Vasarmidi E, Bibaki E, Koutoulaki C, Sato H, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM.

Oncotarget. 2016 Nov 15;7(46):74569-74581. doi: 10.18632/oncotarget.12740.

Supplemental Content

Loading ...
Support Center